HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Christophe Cassel Selected Research

S-2-O-carbamoyl-1-o-chlorophenyl-ethanol

11/2017Neurochemical Changes and c-Fos Mapping in the Brain after Carisbamate Treatment of Rats Subjected to Lithium-Pilocarpine-Induced Status Epilepticus.
7/2017Hippocampal Proteome of Rats Subjected to the Li-Pilocarpine Epilepsy Model and the Effect of Carisbamate Treatment.
5/2014Attention and executive functions in a rat model of chronic epilepsy.
7/2013A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Christophe Cassel Research Topics

Disease

7Memory Disorders (Memory Loss)
02/2015 - 06/2005
5Cognitive Dysfunction
01/2020 - 03/2003
5Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2007
4Seizures (Absence Seizure)
11/2017 - 07/2013
4Hyperthermia
10/2011 - 05/2006
3Temporal Lobe Epilepsy
11/2017 - 05/2014
3Status Epilepticus (Complex Partial Status Epilepticus)
11/2017 - 07/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 10/2010
2Epilepsy (Aura)
07/2017 - 07/2013
1Huntington Disease (Huntington's Disease)
01/2021
1Tauopathies
11/2018
1Anxiety Disorders (Anxiety Disorder)
05/2014
1Absence Epilepsy (Childhood Absence Epilepsy)
07/2013
1Brain Diseases (Brain Disorder)
06/2013
1Vision Disorders (Hemeralopia)
03/2013
1Substance-Related Disorders (Drug Abuse)
10/2011
1Schizophrenia (Dementia Praecox)
12/2010
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2010
1Amyloid Plaque
01/2008
1Dementia (Dementias)
01/2008
1Necrosis
04/2007
1Psychomotor Agitation (Akathisia)
04/2007

Drug/Important Bio-Agent (IBA)

5Cholinergic Agents (Cholinergics)IBA
01/2008 - 06/2006
4LithiumIBA
11/2017 - 07/2013
4Pilocarpine (Ocusert)FDA LinkGeneric
11/2017 - 07/2013
4S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA
11/2017 - 07/2013
4N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
10/2011 - 05/2006
3AcetyltransferasesIBA
11/2018 - 10/2010
2ChromatinIBA
01/2021 - 11/2018
2Ethanol (Ethyl Alcohol)IBA
10/2007 - 05/2006
1Histones (Histone)IBA
01/2020
1EnzymesIBA
01/2020
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
11/2018
1Amino AcidsFDA Link
11/2017
1Diazepam (Valium)FDA LinkGeneric
07/2017
1ProteomeIBA
07/2017
1Peptides (Polypeptides)IBA
02/2015
1Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
02/2015
1Amyloid (Amyloid Fibrils)IBA
02/2015
1Neprilysin (Neutral Endopeptidase)IBA
02/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
09/2014
1Apolipoprotein E4IBA
11/2013
1Pharmaceutical PreparationsIBA
10/2011
1Amphetamine (Amfetamine)FDA LinkGeneric
12/2010
1polyglutamineIBA
10/2010
1Histone Deacetylases (Histone Deacetylase)IBA
10/2010
1Scopolamine (Hyoscine)FDA Link
06/2005
1Muscarinic AntagonistsIBA
06/2005
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2003

Therapy/Procedure

1Oral Administration
02/2015
1Therapeutics
03/2013